- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04122599
Melatonin for Prevention of Post Stroke Delirium
October 9, 2019 updated by: University Hospital Tuebingen
Post stroke delirium is prevalent in 10-30% of all stroke patients.
We aimed to investigate wether Melatonin 2mg may prevent post stroke delirium.
Study Overview
Study Type
Interventional
Enrollment (Anticipated)
2000
Phase
- Phase 2
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Annerose Mengel, MD
- Phone Number: 004970712985354
- Email: annerose.mengel@med.uni-tuebingen.de
Study Locations
-
-
BW
-
Tübingen, BW, Germany, 72076
- Recruiting
- Klinik für Neurologie
-
Contact:
- Annerose Mengel, MD
- Email: annerose.mengle@med.uni-tuebingen.de
-
Contact:
- Christian Bosselmann, MD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
55 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- all patients with stroke, TIA or ICH admitted to our stroke unit or intemdiate care unit
- Stroke / ICH /TIA onset <= 48h
Exclusion Criteria:
- RASS <=4
- severe dementia, psychosis or depression
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Melatonin versus standard care
Melatonin is tested versus standard care
|
Melatonin for prevent post stroke delirium
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Change of delir prevalence
Time Frame: 3months
|
3months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Change of hospital stay
Time Frame: 3months
|
3months
|
Change of antipsychotic drug administration
Time Frame: 3 months
|
3 months
|
Changed stay on stroke unit and/or intermediate care
Time Frame: 3 months
|
3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 1, 2017
Primary Completion (Anticipated)
November 1, 2019
Study Completion (Anticipated)
December 31, 2019
Study Registration Dates
First Submitted
May 29, 2019
First Submitted That Met QC Criteria
October 9, 2019
First Posted (Actual)
October 10, 2019
Study Record Updates
Last Update Posted (Actual)
October 10, 2019
Last Update Submitted That Met QC Criteria
October 9, 2019
Last Verified
October 1, 2018
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Mental Disorders
- Cardiovascular Diseases
- Vascular Diseases
- Cerebrovascular Disorders
- Brain Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Neurologic Manifestations
- Confusion
- Neurobehavioral Manifestations
- Neurocognitive Disorders
- Stroke
- Delirium
- Physiological Effects of Drugs
- Molecular Mechanisms of Pharmacological Action
- Central Nervous System Depressants
- Protective Agents
- Antioxidants
- Melatonin
Other Study ID Numbers
- 752/2018BO2
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Post Stroke Delirium
-
Imperial College Healthcare NHS TrustRecruitingCardiac Surgery | Intensive Care Unit Delirium | Post Operative DeliriumUnited Kingdom
-
Mayo ClinicCompletedPost-Operative DeliriumUnited States
-
Amira Hassan Ahmed AliNot yet recruitingPost Operative DeliriumEgypt
-
Menoufia UniversityCompleted
-
Oregon Health and Science UniversityRecruitingNeurocognitive Disorders | Anesthesia | Post-operative Cognitive Dysfunction | Post-operative DeliriumUnited States
-
Technical University of MunichRecruiting
-
Charite University, Berlin, GermanyRecruiting
-
University of ManitobaUniversity of Washington; University of Toronto; Queen's University; Université...Completed
-
Centre Cardiologique du NordNot yet recruitingPost-operative Delirium | Anaesthetic DepthFrance
-
Ohio State UniversityCompletedPost-operative DeliriumUnited States
Clinical Trials on Melatonin
-
Duquesne UniversityCompleted
-
Peking Union Medical College HospitalCompleted
-
UnivatesAline Patrícia Brietzke; Ana Paula CostellaRecruitingPerimenopausal DisorderBrazil
-
Chinese PLA General HospitalUnknown
-
Assaf-Harofeh Medical CenterNeurim Pharmaceuticals Ltd.UnknownMild Cognitive Impairment (MCI)Israel
-
Qazvin University Of Medical SciencesCompletedPost Partum Haemorrhage in Patients Undergoing Cesarean SectionIran, Islamic Republic of
-
Mayo ClinicRecruitingParkinson Disease | Rapid Eye Movement Sleep Behavior DisorderUnited States
-
Pharmavite LLCKGK Science Inc.Completed
-
Ain Shams UniversityCompletedCerebral Palsy | Growth | Children, Only | MelatoninEgypt
-
Technological Centre of Nutrition and Health, SpainUniversity Rovira i Virgili; Hospital Universitari Sant Joan de Reus; Fundació... and other collaboratorsCompleted